Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Cancer Research|January 23, 2021
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast CancerMartina Di Modica, Giorgio Gargari, Viola Regondi, et al.
Plos One|November 14, 2014
Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophyMarta Dossena, Gloria Bedini, Paola Rusmini, et al.
Cancer Cell International|June 26, 2024
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolutionSerena Mazzucchelli, Lorena Signati, Letizia Messa, et al.
International Journal of Molecular Sciences|August 26, 2022
Bisdemethoxycurcumin (BDC)-Loaded H-Ferritin-Nanocages Mediate the Regulation of Inflammation in Alzheimer's Disease PatientsStella Gagliardi, Marta Truffi, Veronica Tinelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 28, 2018
Increase in chromogranin A- and serotonin-positive cells in pouch mucosa of patients with ulcerative colitis undergoing proctocolectomyPaolo Giuffrida, Alessandro Vanoli, Elena Biletta, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 28, 2023
Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patientsFederica Ferrari, Daniela Rossi, Alessandra Ricciardi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 20, 2018
Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term resultsGianluca M Sampietro, Francesco Colombo, Alice Frontali, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2025
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancerLorenzo Castagnoli, Alma Franceschini, Valeria Cancila, et al.
Pageof 14